Last update:

Immunology news

Immunology

Surprising finding could pave way for universal cancer vaccine

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system ...

Oncology & Cancer

Novel complex induces immunogenic cancer cell death

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the immune system that something ...

Diseases, Conditions, Syndromes

How lung repair mechanisms can help fight against tuberculosis

New research has found that delivering a stronger form of the tuberculosis vaccine directly to the lungs can help generate protective immune cells to help fight the disease. The research is published in the journal Mucosal ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Diseases, Conditions, Syndromes

Measles isn't just dangerous, it may erase your immune system

Blindness, pneumonia, severe diarrhea and even death—measles virus infections, especially in children, can have devastating consequences. Fortunately, we have a safe and effective defense. Measles vaccines are estimated ...

Immunology

Penicillin allergy testing needed to fight antibiotic resistance

Penicillins are first-choice antibiotics for many common infections, but more than one in 15 UK adults have a penicillin allergy label on their medical records. In the event of an infection, they will be prescribed alternative ...

Immunology

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

Immunology

New route into cells could make gene therapies safer

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular ...

Oncology & Cancer

Controlled physical barrier created to boost cancer immunotherapy

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of Sciences (CAS) reported a biomimetic physical barrier (BPB) that temporarily blocks T cell-tumor ...

Immunology

Immunotherapy resistance linked to cytoplasmic WEE1 protein

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells exploit these checkpoints to avoid immune detection. Immune checkpoint blockade (ICB)—a therapy ...

Oncology & Cancer

Comprehensive cell map offers insights into rare brain tumor

Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The CP tumors lead to complications like defective vision, neuronal defects, diabetes, and developmental ...

Oncology & Cancer

Q&A: Interplay between immune cells and HPV keeps skin healthy

Shadmehr (Shawn) Demehri, MD, Ph.D., of the Department of Dermatology and Center for Cancer Immunology at Massachusetts General Hospital, is the corresponding author of a paper published in Cancer Cell, "Commensal papillomavirus ...

Oncology & Cancer

Why copper could be key to treating a rare childhood cancer

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is currently used to manage excess copper in the body—to their treatment.

Genetics

New drug strategy targets rare immune disorders' genetic roots

Several rare immune disorders are caused by mutations in the patient's DNA. In a new study published in the Journal of Clinical Immunology, the University of Surrey and its collaborators found that targeting the mutated pathways ...